Anterra Capital
Anterra Capital is an independent growth capital fund based in Amsterdam, founded in 2013. It specializes in investing in fast-growing companies focused on enhancing the global food supply chain's safety, efficiency, and sustainability. The firm concentrates on supporting companies that are commercializing innovative technologies and services throughout the food supply chain, including agro inputs, precision farming, logistics, and consumer safety. Anterra Capital typically invests between EUR 1 million and EUR 15 million in revenue-generating companies with strong growth potential. As a lead investor, it takes significant minority equity positions and plays an active role on the boards of its portfolio companies. Anterra Capital is committed to long-term investments and collaborates closely with management teams to create lasting value, while also assisting these companies in securing additional capital from professional investors. The firm targets investments in Europe, North America, Asia Pacific, and Latin America, with a focus on food, agriculture technology, and life sciences sectors.
Animol is building its own pipeline of break-through proprietary veterinary small molecules led by a team of animal health industry experts with vast experience in bringing drugs to market. With our unique and powerful technology platform we deliver innovative medicines that are specifically designed for the needs of veterinary patients.
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Ashish Life Science Pvt Limited specializes in the manufacture of veterinary pharmaceuticals aimed at enhancing animal healthcare. Founded in 2002 and based in Mumbai, India, the company produces a diverse range of products for various animal species, including dairy cattle, poultry, pets, horses, and bees. Their product lineup features anti-parasitic, anti-infective, and analgesic medications, alongside supportive therapies. Notable offerings include Ashialben for dairy animals, Ashoxy for poultry, and various formulations for pets and horses. In addition to its manufacturing capabilities, Ashish Life Science also provides contract-manufacturing services. Over the years, the company has established a significant presence in the veterinary export market, building trust with partners in over 50 countries and committing to high-quality healthcare solutions for animals.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.